Cargando…

Hyperoxaluria Induces Endothelial Dysfunction in Preglomerular Arteries: Involvement of Oxidative Stress

Urolithiasis is a worldwide problem and a risk factor for kidney injury. Oxidative stress-associated renal endothelial dysfunction secondary to urolithiasis could be a key pathogenic factor, similar to obesity and diabetes-related nephropathy. The aim of the present study was to characterize urolith...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saenz-Medina, Javier, Muñoz, Mercedes, Rodriguez, Claudia, Contreras, Cristina, Sánchez, Ana, Coronado, María José, Ramil, Elvira, Santos, Martin, Carballido, Joaquín, Prieto, Dolores
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367519/ https://www.ncbi.nlm.nih.gov/pubmed/35954150 http://dx.doi.org/10.3390/cells11152306

Ejemplares similares

Endothelial Dysfunction: An Intermediate Clinical Feature between Urolithiasis and Cardiovascular Diseases
por: Saenz-Medina, Javier, et al.
Publicado: (2022)

Urolithiasis Develops Endothelial Dysfunction as a Clinical Feature
por: Sáenz-Medina, Javier, et al.
Publicado: (2021)

The Bohr Effect Is Not a Likely Promoter of Renal Preglomerular Oxygen Shunting
por: Olgac, Ufuk, et al.
Publicado: (2016)

Activation of the AMP-related kinase (AMPK) induces renal vasodilatation and downregulates Nox-derived reactive oxygen species (ROS) generation
por: Rodríguez, Claudia, et al.
Publicado: (2020)

Enhanced Myogenic Constriction in the SHR Preglomerular Vessels Is Mediated by Thromboxane A2 Synthesis
por: Nademi, Samera, et al.
Publicado: (2020)

Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity
por: Muñoz, Mercedes, et al.
Publicado: (2019)

Hydrogen peroxide derived from NADPH oxidase 4- and 2 contributes to the endothelium-dependent vasodilatation of intrarenal arteries
por: Muñoz, Mercedes, et al.
Publicado: (2018)

Primary Hyperoxaluria Involving the Liver With Crystal Deposits
por: Bansal, Nalini, et al.
Publicado: (2019)

Hospitalization Burden of Patients with Kidney Stones and Metabolic Comorbidities in Spain during the Period 2017–2020
por: Sáenz-Medina, Javier, et al.
Publicado: (2023)

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias
por: Moya-Garzon, Maria Dolores, et al.
Publicado: (2021)

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023)

Primary hyperoxaluria and systemic oxalosis
por: Sriram, K., et al.
Publicado: (2007)

Enteric hyperoxaluria in chronic pancreatitis
por: Demoulin, Nathalie, et al.
Publicado: (2017)

Pancytopenia as a Complication of Primary Hyperoxaluria
por: Khosravi, M., et al.
Publicado: (2019)

The Struggling Odyssey of Infantile Primary Hyperoxaluria
por: Guillaume, Adrien, et al.
Publicado: (2021)

Treatment of primary hyperoxaluria type 1
por: Gupta, Asheeta, et al.
Publicado: (2022)

Improving Treatment Options for Primary Hyperoxaluria
por: Hoppe, Bernd, et al.
Publicado: (2022)

Primary hyperoxaluria: a case series
por: Rather, Jawad Iqbal, et al.
Publicado: (2023)

Bilateral nephrocalcinosis in primary hyperoxaluria type 1
por: Mansoor, C. A., et al.
Publicado: (2016)

ALLN-177, oral enzyme therapy for hyperoxaluria
por: Lingeman, James E., et al.
Publicado: (2019)

Is stiripentol truly effective for treating primary hyperoxaluria?
por: Martin-Higueras, Cristina, et al.
Publicado: (2020)

Primary hyperoxaluria type 1: pathophysiology and genetics
por: Fargue, Sonia, et al.
Publicado: (2022)

Primary hyperoxaluria: the pediatric nephrologist's point of view
por: Ben-Shalom, Efrat, et al.
Publicado: (2022)

Primary hyperoxaluria: the adult nephrologist's point of view
por: Moochhala, Shabbir H, et al.
Publicado: (2022)

Clinical and molecular characterization of primary hyperoxaluria in Egypt
por: Soliman, Neveen A., et al.
Publicado: (2022)

Genetic assessment in primary hyperoxaluria: why it matters
por: Mandrile, Giorgia, et al.
Publicado: (2022)

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria
por: Siener, Roswitha, et al.
Publicado: (2013)

Kidney Stones in Primary Hyperoxaluria: New Lessons Learnt
por: Jacob, Dorrit E., et al.
Publicado: (2013)

Type 1 primary hyperoxaluria in a male infant
por: Waddell, Benjamin, et al.
Publicado: (2017)

Clinical and Genetic Profile of Indian Children with Primary Hyperoxaluria
por: Pinapala, A., et al.
Publicado: (2017)

Limited Treatment Options in Primary Hyperoxaluria with Renal Failure
por: Geiger, Kyle, et al.
Publicado: (2020)

Diet-related urine collections: assistance in categorization of hyperoxaluria
por: Dill, Hannah, et al.
Publicado: (2021)

Primary hyperoxaluria type 1: time for prime time?
por: Bacchetta, Justine, et al.
Publicado: (2022)

Primary hyperoxaluria type 1: urologic and therapeutic management
por: Kohli, Harjivan, et al.
Publicado: (2022)

Risk factors for developing hyperoxaluria in children with Crohn’s disease
por: Salem, Amr, et al.
Publicado: (2022)

The retinal phenotype in primary hyperoxaluria type 2 and 3
por: Birtel, Johannes, et al.
Publicado: (2022)

Primary Hyperoxaluria Type 1 in 18 Children: Genotyping and Outcome
por: Al Riyami, Mohamed S., et al.
Publicado: (2015)

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria
por: Tang, Xiaojing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fa0s9fi7m5ar7g23msqqt0rkb8